Business

FDA may approve COVID-19 drug for 16- and 17-year-olds as soon as next week

The Food and Drug Administration may authorize a COVID-19 booster from Pfizer Inc.
PFE,
-2.96%

and BioNTech SE
BNTX,
+ 4.17%

for use by 16- and 17-year-olds as soon as next week when there is concern about a new, possibly more contagious variant, according to a person familiar with the plan.

The agency is planning to act quickly on requests from companies to license boosters to 16- and 17-year-olds, according to a person familiar with the matter. So far, only people 18 years or older is eligible for boosters.

https://www.marketwatch.com/story/fda-may-ok-covid-boosters-for-16-and-17-year-olds-as-soon-as-next-week-11638237131?rss=1&siteid=rss FDA may approve COVID-19 drug for 16- and 17-year-olds as soon as next week

snopx

Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@interreviewed.com. The content will be deleted within 24 hours.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

3 × 5 =

Back to top button